Home Newsfeeds Eargo Granted U.S. Patent Titled ‘HEARING DEVICE TEST AND DIAGNOSTICS SYSTEM AND METHODS’

Eargo Granted U.S. Patent Titled ‘HEARING DEVICE TEST AND DIAGNOSTICS SYSTEM AND METHODS’

https://ppubs.uspto.gov/pubwebapp/

byBenzinga Newsdesk

October 18, 2022

1 minute read

https://ppubs.uspto.gov/pubwebapp/

IGC Pharma FY23 Revenue Grows 129%, What About Net Loss?

By Vuk Zdinjak

July 12, 10:13 AM

IGC Pharma, Inc. (AMEX:IGC) released its financial results for the fiscal year ended March 31, 2023, revealing revenue of $911,000, an increase of 129% compared to $397,000 in fiscal year 2022. FY 2023 Financial Highlights

IGC

Palvella Therapeutics And Ligand Pharmaceuticals Expand Strategic Partnership To Accelerate Phase 3 Development Of QTORIN Rapamycin For Microcystic Lymphatic Malformations And Additional High Unmet Need Clinical Indications; Palvella Received $5M Payme…

By Benzinga Newsdesk

December 1, 9:23 AM

Palvella Received $5 Million Upfront Payment QTORIN™ rapamycin has Potential to be First FDA Approved Therapy and Standard of Care in the U.S. for an Estimated more than 30,000 Diagnosed Patients with

LGND

M&A
News

FCPT Announces Acquisition Of NAPA Auto Parts Property For $1.4 Million

By Michael Horton

October 19, 5:58 PM

Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the

FCPT